ESR1 Obtainment of stable olive-based micro-/nano-encapsulated extracts.

Use of olive-based encapsulated ingredients.

Production of innovative food products with a high health, nutritional and sensory

Implementation of the application of micro- and nano-encapsulation techniques in


ESR2 Development of nanobiosensors to apply of chemical environmental stressors,
functional food elements.

Use of nanobiosensors to evaluate stressors and food effects in living organism.

Diffusion to the scientific community of novel lab-on-chip platform readily adaptable
to other integrated applications.


ESR7 Definition of the “probiotic” status of fermented food-associated microbes.

Guide line of fermented food/diet that can improve the maintenance of human


ESR4 Experimental data on lipidomic profile of blood cell membrane of healthy (dog, cat and
horse) vs. pathologic animals (metabolic diseases).

identification of the relationship of lipidomic profile as prognostic factor for clinical outcome.
Definition of pharmacological/dietary regimens to overcome lipidomic aberrant profiles.


ESR9 Highlight on the gut microbiome in dogs, cats vs. humans co-habitants under
physiological and pathological conditions (obesity and diabetes mellitus).

effect of diet components on microbioma of physiological obese diabetic animals.

Diet guide line for obese or diabetic pets to adjust microbial unbalance.


ESR10 Acquisition of data on the relationship of genetic background, diet, life style and obesity
with several dismetabolisms, including Type2 diabetes.

Role of SIRT1 in the dismetabolic diseases.

Evaluation of the molecular mechanisms involved on cellular and laboratory mammals models
on the exact pathways that allow SIRT1 to prevent and/or reverse obesity-induced metabolic
disturbances via Resveratrol.



ESR3 Acquisition of data on molecular effect of diet on cell membranes.

Development of computational models of the effects of diet on cell membranes with
experimental data.

Comparative validation of a computational model on diet effect on mammals’ spermatozoa


ESR5 Experimental definition of toxicological effect of OTA dietary exposure on embryo/foetal
development and pregnancy farm animals.

Establishment of the mechanisms on in vitro embryo- and FAD MSC-based models as
alternative method for developmental toxicity.

Guide line for dietary regimen in pregnant livestock animals.


ESR11 Experimental evaluation of the relationship of genetic background, diet, life style and
pollutants on cellular and laboratory animal model (i.e. breast and ovarian cancer) tumour
initiation and progression.

Definition of cellular mechanisms involved in the preventive tumorigenesis action of food


ESR6 Analyze the modifications occurring at molecular and at behavioral level after
treatments with epigenetic modulators.

Evaluate if drugs commercially available as dietary supplement marketed for anti-obesity
therapy, also have effects at the epigenetic levels on genes of interest.

Shed light into the complex relationship between ED and obesity and reproductive
functioning and understand the role of gut microbiota in ED risk factors.


ESR8 Standardize a reliable biological system to monitor ecosystem effects on the aquatic
organisms’ health.

Acquisition of data on the environmental pollutants levels found in monitored areas of the
Abruzzo Region.

Identification of the toxicological effects of environmental pollutants on the reproductive
success of standardized animal model and in vitro models.


ESR12 Identify the feasibility of advanced reproductive technologies to the livestock of
endangered ovine Regional species. M36: Evaluation of nutritional regimen to improve the
advanced use of ovine gametes in ART. M48: Define the possibility of use ART to expand
traditional ovine breeds within an extensive farming context for the production of high
quality meet.


Seguici su:





University of Teramo - Via Renato Balzarini 1 

64100 - Teramo (TE) - Italy  - Private Area

Flag UE

This project has received funding from the European Union’s Horizon 2020 

research and innovation programme under 

the Marie Skłodowska-Curie grant agreement No 713714



Co-funding institutions